Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study
Line Dam Heftdal, Laura Pérez‐Alós, Rasmus Bo Hasselbalch, et al.
EBioMedicine (2023) Vol. 93, pp. 104661-104661
Open Access | Times Cited: 19

Showing 19 citing articles:

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach
Giorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
Xiuwen Wang, Xiaodong Yang, Xin Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Distinct immune responses in people living with HIV following SARS-CoV-2 recovery
Dieter Mielke, Shuying Sue Li, Daniel J. Schuster, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination
María José Muñoz‐Gómez, Pablo Ryan, Marta Quero‐Delgado, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 480-480
Open Access
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
Marlou J. Jongkees, Susanne Bogers, Rory D. de Vries, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0323792-e0323792
Open Access
Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis
Meng-Qun Cheng, Rong Li, Zhiying Weng, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6
Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy
Min Joo Choi, Hakjun Hyun, Jung Yeon Heo, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27211-e27211
Open Access | Times Cited: 2
Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
Lorie Marchitto, Debashree Chatterjee, Shilei Ding, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2004-2004
Open Access | Times Cited: 5
Effect of SARS-CoV-2 Breakthrough Infection on HIV Reservoirs and T-Cell Immune Recovery in 3-Dose Vaccinated People Living with HIV
Mengmeng Qu, Bing Song, Bao-Peng Yang, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2427-2427
Open Access | Times Cited: 5
Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls
Myrthe L. Verburgh, Anders Boyd, Maarten F. Schim van der Loeff, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 7
Open Access | Times Cited: 1
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
Puran Chen, Peter Bergman, Ola Blennow, et al.
EBioMedicine (2024) Vol. 109, pp. 105385-105385
Closed Access | Times Cited: 1
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study
Marcelo Wolff, Paulo Charpentier, Andrea Canals, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 671-676
Open Access | Times Cited: 3
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection
David Niklas Springer, Simon Daller, Michael Knappik, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 822-822
Open Access
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study—ANRS0001s COV-POPART
Paul Loubet, Jean‐Daniel Lelièvre, Alexis François, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107110-107110
Open Access
SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV
Simona Ruță, Corneliu Petru Popescu, Lilia Matei, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 663-663
Open Access
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes
Louise Bering, Line Dam Heftdal, Safura-Luise Heidari, et al.
AIDS (2024) Vol. 38, Iss. 15, pp. 2100-2103
Closed Access
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a Machine Learning approach
Giorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Research Square (Research Square) (2024)
Open Access
Evaluation of the Effect of mRNA and Inactivated SARS-CoV-2 Vaccines on the Levels of Cytokines IL-2, IFN-γ, and Anti-RBD Spike SARS-CoV-2 Antibodies in People Living with HIV (PLHIV)
Amanah Amanah, Ibnu Ariyanto, Budiman Bela, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2115-2115
Open Access
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections
Amin Alirezaylavasani, Linda Gail Skeie, Ingrid M. Egner, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top